Dosage Schedule for Antipyretic Combination Formulations: Correspondence
نویسندگان
چکیده
منابع مشابه
Drug Dosage Formulations
The discovery and development of a new drug can be a lengthy and expensive business (Fig. 1). The starting point is the active compound as synthesized by the medicinal chemist and screened by the pharmacologist. There then follows a series of complex tests and evaluations to produce a satisfactory formulation and sufficient data for presentation to regulatory authorities such as the Committee o...
متن کاملNanomedicine formulations for combination therapies
N anomedicine formulations are nanometer-sized carrier materials designed for improving the biodistribution of systemically applied (chemo-) therapeutic drugs. Clinically relevant examples of nano-medicine formulations are liposomes, polymers and micelles. By delivering pharmacologically active agents more selectively to pathological sites (site-specific drug delivery) and/or by guiding them aw...
متن کاملDosage schedule of gentamicin for chronic renal insufficiency in children.
Gentamicin was given to paediatric patients with chronic renal disease complicated by infections by Gram-negative organisms, in which renal function varied from normal to severely insufficient. Peak serum levels after an intramuscular dose of 1 mg/kg body weight ranged from 3.1 to 9.4 microgram/ml, which appeared adequate for therapy. The peak value was not related to the renal function of the ...
متن کاملMulti-unit dosage formulations of theophylline for controlled release applications.
The study was carried out to investigate the drug release profiles of multi-unit dosage formulations of theophylline consisting of both the fast and slow release components in a unit dose. The fast release component consisted of conventional granules of theophylline formed by mixing the drug powder with starch mucilage (20% w/v) while the slow release component consisted of wax granulations of ...
متن کاملEvaluation of a standard dosage schedule with streptokinase.
T HE FEASIBILITY of producing dissolution of thrombi by enzymatic means has been demonstrated in experimental thrombi and pulmonary emboli in animals, in experimental venous thrombi in man6 and in patients with acute venous and arterial thromboembolic disease.7 8 Of the enzymes investigated, only the two plasminogen activators, streptokinase and urokinase, have proved acceptable as thrombolytic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Indian Journal of Pediatrics
سال: 2013
ISSN: 0019-5456,0973-7693
DOI: 10.1007/s12098-013-0966-2